Organization: Health Canada
Year: 2024
Month: January
Request Number: A-2023-000879
Request Summary: The Inspector’s detailed observations, conditions found, and any follow-up expected by Health Canada for the human drugs establishment licence Good Manufacturing Practices (GMP) inspection of the Apotex facility (Site A) on Signet Drive, Toronto, Ontario starting around February 14, 2023. Reference Number 501259.
Disposition: Disclosed in part
Number of pages: 198